Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NYSE - Nasdaq Real Time Price USD

Alcon Inc. (ALC)

Compare

92.59

-0.11

(-0.12%)

At close: April 2 at 4:00:02 PM EDT

91.01

-1.58

(-1.71%)

After hours: April 2 at 5:41:49 PM EDT

Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter

GENEVA, April 02, 2025--Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter

Business Wire 18 hours ago

ALC
-0.12%
The Zacks Analyst Blog Highlights Alcon, Glaukos and Regeneron Pharmaceuticals

Alcon, Glaukos and Regeneron Pharmaceuticals are part of the Zacks top Analyst Blog.

Zacks yesterday

REGN

ALC.SW

GKOS
Alcon (ALC) Soars 6.0%: Is Further Upside Left in the Stock?

Alcon (ALC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks 5 days ago

NVRO

ALC.SW
Alcon buys majority stake in IPO-seeking cell therapy startup Aurion

The share acquisition is the latest twist in a dispute between Alcon and fellow Aurion shareholder Deerfield Management over the direction of the company, which filed to go public in January.

BioPharma Dive 6 days ago

ALC.SW
Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease

GENEVA, March 26, 2025--Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease

Business Wire 7 days ago

ALC
-0.12%
Alcon Stock Sees RS Rating Climb To 74

A Relative Strength Rating upgrade for Alcon shows improving technical performance. Will it continue?

Investor's Business Daily 8 days ago

ALC
-0.12%
PDEX

PEN
Alcon signs merger agreement to acquire Lensar

The acquisition will include Lensar’s ALLY Robotic Cataract Laser Treatment System and Streamline software technology.

Medical Device Network 8 days ago

ALC.SW
Morning Movers: 23andMe plummets after Chapter 11 proceedings and CEO exit

Stock index futures are experiencing a notable surge, reflecting renewed investor optimism, primarily driven by reports suggesting that the U.S. administration may reduce the scope of proposed tariffs, potentially excluding certain sectors. Such developments have bolstered market sentiment, leading to premarket gains across major indices. In the commodities market, oil prices have experienced a slight decline as investors closely monitor ongoing ceasefire talks between Russia and Ukraine. The

TipRanks 8 days ago

ALC
-0.12%
PENG

OKLO
Alcon Stock Might Rise as Clareon Vivity IOL Secures CE Mark Approval

ALC secures CE Mark for Clareon Vivity IOL, bringing advanced presbyopia-correcting lens technology to Europe, enhancing visual outcomes with cutting-edge innovation.

Zacks 8 days ago

ALC.SW

BSX

CAH
ALC Stock Rises Following the Merger Agreement With LENSAR

Alcon enters into a definitive merger agreement to acquire LENSAR's ALLY Robotic Cataract Laser Treatment System, proprietary Streamline software technology and LENSAR legacy laser system.

Zacks 8 days ago

ALC.SW

MASI

BSX
Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities

GENEVA, March 25, 2025--Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities

Business Wire 9 days ago

ALC
-0.12%
Alcon Agrees to Acquire LENSAR, Inc.

GENEVA, Switzerland & ORLANDO, Fla., March 24, 2025--Alcon Agrees to Acquire LENSAR, Inc.

Business Wire 9 days ago

ALC
-0.12%
Alcon to Host 2025 Capital Markets Day

GENEVA, March 13, 2025--Alcon to Host 2025 Capital Markets Day

Business Wire 20 days ago

ALC
-0.12%
Is it the Right Time to Hold Alcon Stock in Your Portfolio Now?

ALC stays on investors' radar due to its Surgical arm performance and contributions from new products.

Zacks 20 days ago

ALC.SW

BSX
Alcon Stock Gets Relative Strength Rating Lift

A Relative Strength Rating upgrade for Alcon shows improving technical performance. Will it continue?

Investor's Business Daily 29 days ago

PEN

BSX

ALC
-0.12%
Alcon Stock Gains From Innovation Despite Macroeconomic Troubles

Within Vision Care, ALC is registering solid growth, banking on strong sales of its contact lenses and ocular health products.

Zacks last month

ALC.SW
Alcon Canada Strengthens its Commitment to Astigmatic Patients with TOTAL30 for Astigmatism Expanded Parameters

TORONTO, February 27, 2025--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the availability of expanded parameters for TOTAL30® for Astigmatism, the first and only monthly replacement Water Gradient toric contact lens,1-3 delivering the same exceptionally comfortable wearing experience,5 now in a –2.75D cylinder offering.

Business Wire last month

ALC
-0.12%
Alcon Inc (ALC) Full Year 2024 Earnings Call Highlights: Strong Financial Performance and ...

Alcon Inc (ALC) reports robust growth with $9.8 billion in revenue and unveils plans for future expansion and shareholder returns.

GuruFocus.com last month

ALC.SW
Alcon Q4 Earnings Beat, Margins Rise, Stock Remains Stable in Afterhours

ALC's performance is driven by robust demand for its innovative products, balanced geographic footprint and strong execution by the team.

Zacks last month

ALC.SW

CAH

RMD
Alcon (ALC) Reports Q4 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Alcon (ALC) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks last month

ALC.SW

Performance Overview

Return	ALC	MSCI WORLD (^990100-USD-STRD)
YTD	+9.25%	-1.32%
1-Year	+13.26%	+7.16%
3-Year	+17.21%	+20.04%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Alcon Inc. (ALC)

Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter

The Zacks Analyst Blog Highlights Alcon, Glaukos and Regeneron Pharmaceuticals

Alcon (ALC) Soars 6.0%: Is Further Upside Left in the Stock?

Alcon buys majority stake in IPO-seeking cell therapy startup Aurion

Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease

Alcon Stock Sees RS Rating Climb To 74

Alcon signs merger agreement to acquire Lensar

Morning Movers: 23andMe plummets after Chapter 11 proceedings and CEO exit

Alcon Stock Might Rise as Clareon Vivity IOL Secures CE Mark Approval

ALC Stock Rises Following the Merger Agreement With LENSAR

Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities

Alcon Agrees to Acquire LENSAR, Inc.

Alcon to Host 2025 Capital Markets Day

Is it the Right Time to Hold Alcon Stock in Your Portfolio Now?

Alcon Stock Gets Relative Strength Rating Lift

Alcon Stock Gains From Innovation Despite Macroeconomic Troubles

Alcon Canada Strengthens its Commitment to Astigmatic Patients with TOTAL30 for Astigmatism Expanded Parameters

Alcon Inc (ALC) Full Year 2024 Earnings Call Highlights: Strong Financial Performance and ...

Alcon Q4 Earnings Beat, Margins Rise, Stock Remains Stable in Afterhours

Alcon (ALC) Reports Q4 Earnings: What Key Metrics Have to Say

Performance Overview